Novavax Takes Another Step Toward FDA Approval
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It's completely free and we guarantee you'll learn something new every day.
Slow and steady wins the race, right? Well, not when it comes to a finite pandemic.
Nearly fifteen months after the first coronavirus vaccine gained emergency use authorization by the US FDA (and 555 million jabs in American arms later), Maryland-based Novavax is one step closer to bringing its once-promising COVID jab to market.
Source Fool.com
